Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,203,885
-
Total 13F shares
-
2,154,610
-
Share change
-
-76,542
-
Total reported value
-
$122,645,130
-
Price per share
-
$56.92
-
Number of holders
-
109
-
Value change
-
-$4,286,491
-
Number of buys
-
54
-
Number of sells
-
51
Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q2 2025
As of 30 Jun 2025,
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,154,610 shares.
The largest 10 holders included
BRANDES INVESTMENT PARTNERS, LP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, Minerva Advisors LLC, STATE STREET CORP, and RICE HALL JAMES & ASSOCIATES, LLC.
This page lists
110
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.